IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Jul 2002 (Vol: 2002, Issue: 26)

Next Issue >>

Download pdf of entire issue

Section: Company Profile
H. Lundbeck AS Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Par Pharmaceutical to Market Three Rivers’ Ribavirin Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:
Women First HealthCare Acquire Vaniqa from BMS Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:
ICN to Market Pharmacia Products in Italy Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:
Section: General
Big Pharma Product Divestments– Buying the Cast-Offs Published: 2 Jul-2002
By: Business Review Editor
Abstract
Shortening the Adoption Curve Published: 2 Jul-2002
By: Business Review Editor
Abstract
Technology Focus: Pharmacogenomics Published: 2 Jul-2002
By: Business Review Editor
Abstract
Section: Licensing
Stressgen Licenses Heat Shock Fusion Protein to Roche Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:
Micrologix Licenses Anti-Infective to Fujisawa Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:
VaxGen Amends Agreement with Genentech for AIDSVAX Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Pfizer to Acquire Pharmacia Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:
Serono Launches Bid to Acquire Genset Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Arakis and GeneFormatics Collaborate on Performance Enhanced Medicines Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:
Centocor and Neuronyx Enter Cardiovascular Stem Cell Collaboration Published: 2 Jul-2002
By: Business Review Editor
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in